CellPly CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment. | ![]() ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ![]() Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. | |
Founding Date | Founding Date 2013 | Founding Date 1981 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Bologna, IT HQ Bologna, IT | Locations Waltham, US HQ | Locations Seattle, US HQ |
Employees | Employees 313% decrease | Employees 277161% increase | Employees 1182% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) 4.1 m |
Financial | |||
Net income | Net income N/A | Net income ($222.9m) (FY, 2022) | Net income ($26m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 5.9m | Total funding raised $ 56m | Total funding raised N/A |

ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View company